Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GenomIdea

2002 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of novel therapeutic drugs. The company's novel therapeutic drugs include anti-cancer drugs, nucleic acid medicines and DNA vaccines, enabling patients to reduce their cancer and other infectious diseases more effectively.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 4F, Saito Bio-Incubator, 7-7-15
  • Saito-asagi, Ibaraki
  • Osaka, 567-0085
  • Japan

GenomIdea Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GenomIdea‘s full profile, request access.

Request full access to PitchBook

GenomIdea Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore GenomIdea‘s full profile, request access.

Request full access to PitchBook

GenomIdea Executive Team (1)

Name Title Board
Seat
Contact
Info
Toshihiro Nakajima President & Chief Executive Officer